covid
Buscar en
Revista Portuguesa de Estomatologia, Medicina Dentária e Cirurgia Maxilofacial
Toda la web
Inicio Revista Portuguesa de Estomatologia, Medicina Dentária e Cirurgia Maxilofacial Xerostomia. Etiologia e Tratamento
Información de la revista
Vol. 50. Núm. 3.
Páginas 159-164 (julio - septiembre 2009)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 50. Núm. 3.
Páginas 159-164 (julio - septiembre 2009)
Revisão
Open Access
Xerostomia. Etiologia e Tratamento
Visitas
18773
Filipe Coimbra
Médico Dentista. Professor auxiliar de Medicina Oral. Faculdade de Medicina Dentária da Universidade do Porto
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Resumo

Neste trabalho de revisão estabelece-se em primeiro lugar a distinção entre xerostomia simples, sensação de boca seca com marcada diminuição do fluxo salivar em repouso (FSR), e hipossialia, em que há diminuição simultânea do fluxo salivar estimulado (FSE) que ocorre durante as refeições, e somente na qual há lesão dos ácinos glandulares. Frisa-se que entre as causas de xerostomia não se inclui o envelhecimento, mas sim o uso continuado de determinadas medicações, a irradiação terapêutica da cabeça e pescoço e a síndrome de Sjögren. Em seguida, insiste-se na semiologia objectiva a pesquisar pelo estomatologista nos doentes que se queixam de boca seca. Finalmente passam-se em revista as medidas terapêuticas indicadas, quer de natureza geral, suficientes nos casos benignos de xerostomia, quer em casos mais marcados o uso de salivas artificiais. Revêem-se depois os medicamentos causativos de xerostomia, os anticolinérgicos, os antidepressivos tricíclicos, os anti-hipertensores e sobretudo os diuréticos, únicos responsáveis pela baixa do FSE. Nos casos de radiação, o uso de placas protectoras das glândulas, e de citoprotectores como a amifostina durante a irradiação e a pilocarpina depois da mesma. Finalmente na síndrome de Sjögren, recomenda-se o uso reforçado das medidas gerais e nomeadamente os sialogogos selectivos, tais como a pilocarpina e a cevimalina.

Palavras-Chave:
Saliva
Xerostomia
Hipossialia
Síndrome de Sjögren
Medicações
Radioterapia
Abstract

In this present review the difference is, at first, stressed between simple xerostomia, a sensation of dry mouth with marked decrease of the resting salivary flow (RSF) and hyposalivation, in which there is an additional decrease of the stimulated salivary flow(SSF) that occurs during meals, and which is the only one due to lesions of the glandular secretory acini. It is remarked that the main causes of xerostomia are excessive medication, therapeutic X-rays of head and neck, and the syndrome of Sjögren, with the exclusion of ageing. In addition, the objective signs that should be sought after in patients with chronic dry mouth by the dental practitioner are described. Next, the therapeutic measures to be carried out, either the generic ones in mild cases, or the use of artificial salivas in more severe conditions, are reviewed. Thereafter, mention is made of the drugs causing xerostomia, such as anticholinergic, tricyclic antidepressive, and antihypertensive medications, as well as diuretics, the only ones affecting the SSF. In cases of xerostomia depending on X-rays it is advised to use protective plates for the salivary glands, and the administration of cytoprotective drugs, namely amifostine during the radiation procedures and pilocarpine after them. In the Sjögren syndrome, it is recommended an intensification of the general therapeutic measures, and also the use of selective syalogogues such as pilocarpine and cevimaline.

Key-words:
Saliva
Xerostomia
Hyposalivaton
Sjögren's syndrome
Medications
Radiotherapy
El Texto completo está disponible en PDF
Bibliografia
[1-]
M.T. Brennan, G. Shariff, P.B. Lockhart, P.C. Fox.
Treatment of xerostomia: a systemic review of therapeutic trials.
The Dental Clinics of North America, 46 (2002), pp. 847-856
[2-]
J. Guggenheimer, P.A. Moore.
Xerostomia: etiology, recognition and treatment.
JADA, 134 (2003), pp. 61-69
[3-]
E.M. Ghezzi, L.A. Lange, J.A. Ship.
Determination of variation of stimulated salivary flow rates.
J Dent Res, 79 (2000), pp. 1874-1878
[4-]
B.J. Baum.
Evaluation of stimulated parotid saliva flow rate in different age groups.
J Dent Res, 60 (1981), pp. 1292-1296
[5-]
M. Navazesh, V.J. Brightman, J.M. Pogoda.
Relationship of medical status, medication, and salivary flow rates in adults of diferents ages.
Oral Surg Oral Med Oral Pathol Oral Endod, 81 (1996), pp. 172-176
[6-]
T.O. Narhi.
Prevalence of subjective feelings of dry mouth in the elderly.
J Dent Res, 73 (1994), pp. 20-25
[7-]
L.M. Screebny, S.S. Schwartz.
2nd edition, Gerontology, (1997),
[8-]
J.A. Ship, P.C. Fox, B.J. Boum.
How to mutch saliva is enough to normal function defined.
JADA, 122 (1991), pp. 63-69
[9-]
P.C. Fox, P.F. van der Vem, B.C. Sonies, J.M. Eeiffenbach, B.J. Baum.
Xerostomia: evaluation of a symptom with increasing significance.
J Am Dent Assoc, 110 (1985), pp. 519-525
[10-]
O.P. Vicent, N.A. Marqués, C.G. Escoda.
Minor salivary gland tumors: A clinicopathological study of 18 cases.
Med Oral Patol Oral Cir Bucal, 13 (2008), pp. 582-588
[11-]
C.E. Christensen, L. Lindth, T. Arnenbrant.
Film-forming properties and viscosities of saliva substitutes and human whole saliva.
European Journal of Sciences, 108 (2000), pp. 418-425
[12-]
L.H. Meyer, M.J. Schulte, A.M. Kielbassa.
The effect of commercially available saliva substituts on predmineralized bovine dentin in vitro.
Oral Diseases, 8 (2002), pp. 192-198
[13-]
M. Rode, l. Sunid, M. Budihana, E. Soba.
Gaspusic d. the effect of pilocarpine and biperidine on salivary secretion during and after radiotherapy in head and neck cancer patients.
Int. J. Radiation Oncology Biol. Phys, 45 (1999), pp. 337-378
[14-]
C.H. Shiboski, T.A. Hodgson, J.A. Ship, M. Schiodt.
Management of salivary hypofunction during and after radiotherapy.
Oral Surg Oral Med Oral Pathol Oral Radiol Oral Endod, 103 (2007),
[15-]
J.L Atkinson, A.J. Wu.
Salivary gland dysfunction: causes, symptoms and treatment.
J Am Dent Assoc, 125 (1994), pp. 409-416
[16-]
J.J. Sciubba, D. Goldenberg.
Oral complications of radiotherapy.
Lancet Oncol, 7 (2006), pp. 175-183
[17-]
A.V.N. Amerongen, E.C. Veeman.
Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies.
Support Care Cancer, 11 (2003), pp. 226-231
[18-]
C.H. Shiboski, T.A. Hodgson, J.A. Ship, M. Schiodt.
Management of salivary hypofunction during and after radiotherapy.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontics, 103 (2007),
[19-]
S.F. Cassolato, R.S. Turnbull.
Xerostomia: clinical aspects and treatment.
Gerodontology, 20 (2003), pp. 7789
[20-]
C.M. Rubira, et al.
Evaluation of same oral postradiotherapy sequelae in patients treated for head and neck tumors.
Braz Oral Res, 21 (2007), pp. 272-277
[21-]
J. Pjipe, W.W.I. Kalkn, F.K.L. Spujukerver, C.G.M. Kallenberg, A. Vissink.
Progression of salivary gland dysfunction in patients with Sjögren Syndrome.
Annals of the Rheumatic Disease, (2007),
[22-]
Fox. Philip.
Salivary Enhancement Therapies.
Caries Res, 38 (2004), pp. 241-246
[23-]
A.E. Sotto-Rojas, A. Kraus.
The oral Side of Sjögren syndrome. Diagnosis and treatment. A review.
Archives of Medical Research, 33 (2002), pp. 95-106
[24-]
L.J. Dawson, V.L. Caulfield, J.B. Stanbury, A.E. Field, S.E. Christmas, P.M. Smith.
Hydroxichloroquine therapy in patients with primary Sjogrens syndrome may improve salivary gland hypofunction of glandular cholinesterase.
Rheumatology, 44 (2005), pp. 449-458
[25-]
N.L. Rhodus.
Sjogren syndrome Quintissence International, 30 (1999), pp. 689-698

(Coimbra F. Xerostomia. Etiologia e Tratamento. Rev Port Estomatol Cir Maxilofac 2009;50:159–164)

Copyright © 2009. Sociedade Portuguesa de Estomatologia e Medicina Dentária
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos